Please login to the form below

Not currently logged in
Email:
Password:

Vargatef

This page shows the latest Vargatef news and features for those working in and with pharma, biotech and healthcare.

NICE rejects Opdivo for lung cancer once again

NICE rejects Opdivo for lung cancer once again

NICE says that second-line patients should now be offered docetaxel or Boehringer Ingelheim's Vargatef (nintedanib).

Latest news

More from news
Approximately 4 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera Group

Welcome to Frontera Group where our agencies immerse you into the world of the patient....

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics